Lymphatic vascular morphogenesis in development, physiology, and disease
S Schulte-Merker, A Sabine, TV Petrova - Journal of Cell Biology, 2011 - rupress.org
S Schulte-Merker, A Sabine, TV Petrova
Journal of Cell Biology, 2011•rupress.orgAbbreviations used in this paper: BEC, blood endothelial cell; FN, fibronectin; GD, Gorham
disease; HLT, hypotrichosis–lymphedema–telangiectasia syndrome; KS, Kaposi sarcoma;
KSHV, KS-associated herpes virus; LAM, lymphangioleiomyomatosis; LEC, lymphatic
endothelial cell; LD, lymphedema–distichiasis syndrome; mTOR, mammalian target of
rapamycin; NFAT, nuclear factor of activated T cells; PI, phosphoinositide; SMC, smooth
muscle cell; Syk, spleen tyrosine kinase.
disease; HLT, hypotrichosis–lymphedema–telangiectasia syndrome; KS, Kaposi sarcoma;
KSHV, KS-associated herpes virus; LAM, lymphangioleiomyomatosis; LEC, lymphatic
endothelial cell; LD, lymphedema–distichiasis syndrome; mTOR, mammalian target of
rapamycin; NFAT, nuclear factor of activated T cells; PI, phosphoinositide; SMC, smooth
muscle cell; Syk, spleen tyrosine kinase.
Abbreviations used in this paper: BEC, blood endothelial cell; FN, fibronectin; GD, Gorham disease; HLT, hypotrichosis–lymphedema–telangiectasia syndrome; KS, Kaposi sarcoma; KSHV, KS-associated herpes virus; LAM, lymphangioleiomyomatosis; LEC, lymphatic endothelial cell; LD, lymphedema–distichiasis syndrome; mTOR, mammalian target of rapamycin; NFAT, nuclear factor of activated T cells; PI, phosphoinositide; SMC, smooth muscle cell; Syk, spleen tyrosine kinase.
rupress.org